CURE

Daily healthy rituals you can feel good about.

General Information
Company Name
CURE
Founded Year
2019
Location (Offices)
New York, United States +1
Founders / Decision Makers
Number of Employees
41
Industries
Food and Beverage
Funding Stage
Series B
Social Media

CURE - Company Profile

CURE

CURE is a New York City-based functional beverage brand, backed by venture capitalists and pioneering a range of products for daily healthy rituals. Their Electrolyte Drink Mix is grounded in the Oral Rehydration Solution, a well-balanced formula by the World Health Organization, boasting 4x the electrolytes of a sports drink and free from added sugars. The brand also offers Energizing Drink mixes with natural caffeine to aid recovery from daily stressors.

Noteworthy investors in CURE include Lerer Hippeau, Beliade, Silas Capital, Simple Food Ventures, Great Oaks, Litani Ventures, along with prominent individuals such as Carly Strife, Kathleen King, Philip Krim, Nick Green, Nas, Andy Roddick, and Kim Clijsters. Additionally, the brand is supported by a distinguished Medical Advisory Board comprised of Dr. Roshini Raj, Dr. Dana Cohen, and Brooke Alpert.

CURE products are available on their website, Amazon, Thrive Market, and in over 13,000 stores including CVS, Walgreens, Sprouts, Kroger, Albertsons, Gelsons, Erehwon, and CIBO Market. The company has made its mark by securing the #10 spot in Food & Beverage and #225 overall on Inc. 5000's 2023 list of fastest-growing private companies in America.

Founded in 2019 and operating in the Food and Beverage industry, CURE has recently attracted a Series B investment from Morrison Seger Venture, Rocana Ventures, Stella Capital, Marc Lore, and Wellness Growth Ventures on 23 October 2023.

Taxonomy: functional beverage brand, electrolyte drink mix, hydration, recovery, venture-backed, premium ingredients, medical advisory board, female-founded, retail expansion, plastic neutral, health and wellness, fast-growing company, investor-backed

Funding Rounds & Investors of CURE (4)

View All
Funding Stage Amount No. Investors Investors Date
Series B Unknown 5 Marc Lore, Rocana Venture Partners +2 23 Oct 2023
Series A $5.60M 5 Morrison Seger Venture Capital Partners 17 Apr 2023
Seed Round $2.61M - 18 Aug 2020
Pre Seed Round Unknown - 31 Aug 2018

Latest News of CURE

View All

No recent news or press coverage available for CURE.

Similar Companies to CURE

View All

No funding or investment information available for CURE at this time.